Grow Opportunity

University of Calgary, Sundial Growers sign research deal

Sundial Growers Inc. has signed a three-year memorandum of understanding for collaborative research with the University of Calgary to conduct research and clinical studies on cannabis for medicinal purposes, the cannabis producer announced.

July 17, 2018  By Grow Opportunity staff

Rendering of the interior of one of Sundial's state-of-the-art custom built modular cultivation rooms

The partnership aligns with the University of Calgary’s strategic research areas of brain and mental health, as well as infections, inflammation and chronic diseases.

“Sundial is thrilled to sign this partnership agreement with the University of Calgary and we look forward to working with the Cumming School of Medicine’s Hotchkiss Brain Institute, as well as other institutes and departments, to find opportunities for world-class research and clinical studies of cannabis strains for medicinal purposes,” said Sundial’s president, Geoff Thompson.

“Partnership agreements with world-class research institutions such as the University of Calgary are important for Sundial as we work towards becoming a leading international medical cannabis company.”

Through the agreement, the University of Calgary and Sundial will work together to define and implement research and clinical studies that meet the strategic goals of both organizations, the press statement said. The parties will also look to create opportunities to sponsor specific trainees and faculty for projects related to the advancement of the understanding of medicinal applications of cannabis and to secure partnership funding to establish research chairs and trainee sponsorships for specific research projects.


Related: The business case for research

“Early research into the possible benefits of medicinal cannabis shows promise. This agreement with Sundial will put the University of Calgary at the forefront of the scientific advancement of medicinal cannabis as a treatment option for a number of medical conditions,” said Dr. Keith Sharkey, interim director, Hotchkiss Brain Institute. “Sundial’s approach to growing cannabis in their specialized cultivation modules makes them a strong partner for the University of Calgary, which needs a consistent and quality supply of cannabis for research purposes.”

Sundial and the University of Calgary will collaborate over the coming months to develop projects of mutual interest to both parties. Once projects are determined, the parties will enter into separate project agreements that will define specific goals and be governed by standard clinical trial protocols.

Sundial currently operates a 31,000-square-foot cannabis production facility in Rocky View, Alta., and has two separate production facilities in various stages of completion and licensing.

The Hotchkiss Brain Institute at the University of Calgary consists of more than 140 scientists and clinician-scientists who are dedicated to advancing brain and mental health research and education.

Print this page


Stories continue below